Haloperidol serum concentrations in critically ill patients included in the REDUCE study

Intensive Care Med. 2018 Oct;44(10):1774-1775. doi: 10.1007/s00134-018-5348-9. Epub 2018 Aug 24.

Authors

Anne W van Schijndel¹, Eric J F Franssen², Peter Pickkers³, Saskia Rijkenberg¹, Mark van den Boogaard³, Peter H J van der Voort⁴

Affiliations

¹ Department of Intensive Care, OLVG Hospital, 95500, 1090, Amsterdam, The Netherlands.
² Department of Clinical Pharmacy, OLVG Hospital Amsterdam, Amsterdam, The Netherlands.
³ Department of Intensive Care, Radboud UMC Nijmegen, Nijmegen, The Netherlands.
⁴ Department of Intensive Care, OLVG Hospital, 95500, 1090, Amsterdam, The Netherlands. p.h.j.vandervoort@olvg.nl.

PMID: 30143834
DOI: 10.1007/s00134-018-5348-9

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents* / pharmacokinetics
Critical Illness*
Delirium
Haloperidol* / pharmacokinetics
Humans

Substances

Antipsychotic Agents
Haloperidol